š Patient Eligibility
Inclusion Criteria:
- Adult women (age 18ā65)
- Classic symptoms: dysuria, urinary frequency, urgency, suprapubic discomfort
- No vaginal discharge or irritation
- No fever (>99.9°F/37.7°C), flank pain, or systemic symptoms
Exclusion Criteria:
- Pregnant women
- Men
- Immunocompromised patients
- Known urologic abnormalities (e.g., neurogenic bladder, stones)
- Indwelling catheters
- Recent urologic procedure
- Symptoms suggestive of pyelonephritis (fever, chills, flank pain, nausea/vomiting)
- Recurrent UTI (>3/year)
- Recent antibiotic use (within 4 weeks)
- Allergy to first-line antibiotics
Ā
ā History Taking (via Telemedicine)
- Onset, duration, and severity of symptoms
- Presence of dysuria, frequency, urgency, hematuria, suprapubic pain
- Absence of vaginal symptoms (discharge, irritation)
- Fever, chills, back/flank pain, nausea/vomiting
- Sexual history, contraception, last menstrual period (if relevant)
- Past UTI history, prior antibiotic use, allergies
- Comorbidities (diabetes, immunosuppression, renal disease)
- Pregnancy status
Ā
āš¼ Assessment
- If classic lower urinary tract symptoms are present and no exclusion criteria, proceed with empiric treatment.
- If symptoms are atypical or exclusion criteria are met, recommend in-person evaluation and/or urinalysis/culture.
Ā
š¼ Management
First-Line Empiric Therapy (Uncomplicated Cystitis):
- Nitrofurantoin 100 mg PO BID x 5 days (avoid if CrCl <30 mL/min)
- Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg PO BID x 3 days (if local resistance <20% and no allergy)
- Fosfomycin 3 g PO single dose (less preferred due to lower efficacy)
Alternatives (if above contraindicated):
- Beta-lactams (e.g., amoxicillin-clavulanate, cefdinir) x 5ā7 days (less preferred due to lower efficacy)
Symptomatic Relief:
- Phenazopyridine 200 mg PO TID x 2 days (optional, for dysuria)
Ā
š© Follow-Up and Red Flags
-
Advise patient to follow up if:
- Symptoms persist >48ā72 hours after starting antibiotics
- Develops fever, flank pain, nausea/vomiting
- Allergic reaction to medication
- If symptoms worsen or pyelonephritis suspected, refer for in-person evaluation and possible urine culture.
Ā
š Documentation
- Document all history, assessment, rationale for telemedicine management, antibiotic choice, and patient education.
- If UTI is recurrent or complicated, recommend urine culture and/or referral.
Ā
⨠Special Considerations
- For patients with recurrent UTIs, consider further workup and urology referral.
- For postmenopausal women, consider vaginal estrogen if recurrent UTIs.
Ā
ā ļø Note: This protocol is for uncomplicated cystitis in non-pregnant adult women.
Ā

Comments (0)